Interneuron deal

IPIC acquired Cardiovascular Pharmacology and Engineering Consultants (CPEC), which is developing bucindolol, a beta blocker to treat heart failure.

IPIC will pay an undisclosed number of shares and certain reimbursement expenses to CPEC. Following the acquisition, IPIC will continue to operate the Denver unit as a virtual company, keeping its two employees. ...